Type
1.
Oliveira MG, Walsh-Monteiro A, Araújo JF, Oliveira MA. Epidemiology of Acute Chagas Disease in the Amazon: Association between the açaí production chain and case reports in Pará state, Brazil. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2026;59:1-7. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC13035243/pdf/1678-9849-rsbmt-59-e0360-2025.pdf
Type
1.
Velez ASMM, Chaves OA, Costa T, Serpa C, Borges J de M, Freire-de-Lima CG, et al. Structure-enabled enhancement of potency in a metronidazole-benznidazole hybrid: design, synthesis, and evaluation of antitrypanosomal activity of a benzylamide-linked 5-nitroimidazole. Frontiers in pharmacology [Internet]. 2026;17:1-11. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC13171372/pdf/fphar-17-1812023.pdf
Type
1.
Higuita NIA, Henao-Martínez AF, Batista MV, Bernal CPH, Filho JR, Rassi A. State-of-the-Art Review: Chagas Disease-an Enduring Challenge. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Internet]. 2026;82(2):187-205. Available from: https://academic.oup.com/cid/article-pdf/82/2/187/67112776/ciaf654.pdf
Type
1.
Lori Ferrins, Luiza Cruz, William C. K. Pomerantz, Félix Calderón. Call for Papers: Bridging Gaps in Global Health with Medicinal Chemistry. Journal of Medicinal Chemistry [Internet]. 2025;68(23):1-2. Available from: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03349?ref=article_openPDF
Type
1.
Watson JA, Cruz C, Barreira F, Forsyth C, Schijman AG, Peploe R, et al. Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials. The Lancet Microbe [Internet]. 2025;:1-10. Available from: https://www.thelancet.com/action/showPdf?pii=S2666-5247%2825%2900084-9
Type
1.
Ebiloma GU School of Science, Engineering & Environment, University of Salford, Manchester M5 4NT, UK, Alhejeli A Biology Department, Darb University College, Jazan 45142, Saudi Arabia, de Koning HP School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK. Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment. Pharmaceuticals [Internet]. 2025;18(9):1-51. Available from: https://www.mdpi.com/1424-8247/18/9/1415/pdf?version=1758536515
Type
1.
Beatty NL, Hamer GL, Moreno-Peniche B, Mayes B, Hamer SA. Chagas Disease, an Endemic Disease in the United States. Emerging infectious diseases [Internet]. 2025;31(9):1691-7. Available from: https://wwwnc.cdc.gov/eid/article/31/9/pdfs/24-1700.pdf
Type
1.
Crespillo-Andújar C, Perez-Molina JA. The importance of long-term follow-up data in Chagas disease: new challenges for old paradigms. Clinical Microbiology and Infection [Internet]. 2025; Available from: https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(25)00311-8/abstract
Type
1.
Escalante-Pérez IA, Alviares AA, Omaña-Ávila ÓD, Carrión-Nessi FS, Mendoza-Millán DL, Erimee-Vieira G de J, et al. Prevalence, knowledge, attitudes, and practices regarding Chagas disease in Guanare, Venezuela: a cross-sectional study. Parasites & Vectors [Internet]. 2025;18(1):10. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12147284/pdf/13071_2025_Article_6846.pdf
Type
1.
Palmeirim AF, Barreto JR, Prist PR. The importance of Indigenous Lands and landscape structure in shaping the zoonotic disease risk—Insights from the Brazilian Atlantic Forest. One Health [Internet]. 2025;21:1-9. Available from: https://www.sciencedirect.com/science/article/pii/S2352771425001405